Processa Pharmaceuticals Issues Letter To Shareholders Highlighting Corporate Strategy, Drug Pipeline, And Outlook
Processa Pharmaceuticals, Inc. (NASDAQ:PCSA) ("Processa" or the "Company"), a clinical-stage pharmaceutical company now focused on developing the next generation of chemotherapeutic drugs to improve the efficacy and